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Polyamines are small cations with unique combinations of charge and length that give them
many putative interactions in cells. Polyamines are essential since they are involved in repli-
cation, transcription, translation, and stabilization of macro-molecular complexes. However,
polyamine synthesis competes with cellular methylation for S-adenosylmethionine, the
methyl donor. Also, polyamine degradation can generate reactive molecules like acrolein.
Therefore, polyamine levels are tightly controlled. This control may be compromised in
autoimmune diseases since elevated polyamine levels are seen in autoimmune diseases.
Here a hypothesis is presented explaining how polyamines can stabilize autoantigens. In
addition, the hypothesis explains how polyamines can inappropriately activate enzymes
involved in NETosis, a process in which chromatin is modified and extruded from cells as
extracellular traps that bind pathogens during an immune response.This polyamine-induced
enzymatic activity can lead to an increase in NETosis resulting in release of autoantigenic
material and tissue damage.
Keywords: polyamines, NETosis, autoimmune disease, peptidylarginine deiminase, nuclear aggregates of
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INTRODUCTION
Polyamines (putrescine, spermidine, and spermine) (Figure 1A)
are essential for transcription, translation, replication, modulation
of ion channels, modulation of receptor binding, and stabilization
of many nucleoprotein complexes (Moinard et al., 2005; Pegg,
2009). The unique combination of length and high positive charge
at physiological pH found in polyamines gives them the potential
for many interactions with anions such as RNA, DNA, phos-
pholipids, and ATP. However, excessive levels of polyamines have
the potential to interfere with cellular processes and, therefore,
polyamine synthesis must be controlled. For example, polyamine
synthesis competes with essential cellular methylation for the
methyl donor, S-adenosylmethionine (SAM). In eukaryotic cells,
spermidine and spermine are usually present at 0.5–1.2 mM con-
centrations but putrescine is kept at only trace amounts when not
needed since polyamine synthesis can be controlled by limiting
putrescine. Putrescine is produced by a key enzyme in polyamine
synthesis, ornithine decarboxylase (ODC) (Figure 1B). ODC is
one of the most tightly controlled enzymes in cells with rapid
turnover of ODC mRNA and protein and existence of an antizyme
to help with ODC suppression (Pegg, 2006). Besides being the pre-
cursor for synthesis of higher polyamines, putrescine controls the
self-processing conversion of SAM decarboxylase (AMD1) proen-
zyme to the active enzyme (Pegg, 2009). In addition, putrescine
can bind an allosteric site in AMD1 that increases AMD1 activ-
ity eightfold converting SAM to decarboxylated SAM (dcSAM)
(Bale et al., 2008). The dcSAM provides the amino propyl groups
needed in polyamine synthesis. Cellular methyltransferases cannot
use dcSAM, thus the need to keep putrescine and polyamine syn-
thesis at low levels in order to control AMD1 activity and preserve
SAM for methylation.
Increased levels of polyamines as well as increased polyamine
synthesis and recycling have been seen in autoimmune diseases
(Tetia et al., 2002; Karouzakis et al., 2012). The polyamines are
usually bound non-covalently to major anions, such as DNA,
RNA, and phospholipids, and only 2–15% of polyamines are free
(Igarashi and Kashiwagi, 2010). Polyamine synthesis and recycling
can greatly increase in response to cellular stress so that the free
polyamines produced can bind and help stabilize disrupted macro-
molecular complexes. Excessive cellular stresses could result in
higher levels of polyamines. Another reason that cells need to keep
polyamine levels under control is because polyamine degrada-
tion can generate toxic reactive molecules such as acrolein and
hydrogen peroxide.
NUCLEAR AGGREGATES OF POLYAMINES
Interactions of individual polyamines have typically been the focus
of polyamine research but several key studies have begun the char-
acterization of nuclear aggregates of polyamines (NAPs) (Pignata
et al., 1999; D’Agostino and Di Luccia, 2002; D’Agostino et al.,
2005). NAPs show a consistency as structures of approximately 1,
5, and 8 kDa which are identified as a small-size NAP (s-NAP),
medium-size NAP (m-NAP), and large-size NAP (l-NAP), respec-
tively. Similar structures are seen in vivo and in vitro (Iacomino
et al., 2012). In vitro analysis has shown that polyamines slowly
self-assemble with phosphate ions into the ring-like NAP struc-
tures (Figures 2A–C) (Iacomino et al., 2011). NAPs contain fixed
ratios of polyamines and phosphate ions, believed to be primarily
in the HPO−24 state found in mildly basic physiological conditions.
For the s-NAP (Figure 2B), the proposed structure is a single ring
composed of one putrescine, one spermidine, and two spermine
molecules, along with phosphate ions (D’Agostino et al., 2005).
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FIGURE 1 |The polyamine pathway. (A) Polyamines at physiological pH:
Putrescine (+2, ∼8Å), Spermidine (+3, ∼12Å), Spermine (+4, ∼16Å). (B)
Polyamine synthesis and recycling. S-adenosylmethionine decarboxylase
(AMD1) and ornithine decarboxylase (ODC) are rate limiting steps in
polyamine synthesis. AMD1 decarboxylates S-adenosylmethionine (SAM)
to decarboxylated SAM (dcSAM) so that dcSAM can provide aminopropyl
groups added to putrescine to make spermidine by spermidine synthase
(SRM) and added to spermidine to make spermine by spermine synthase
(SMS). Spermine can be recycled to spermidine directly by spermine
oxidase (SMOX). Spermine and spermidine can be recycled to spermidine
and putrescine, respectively, by spermidine/spermine-N1-acetyltransferase
(SAT1) followed by oxidation by polyamine oxidase (PAO).
The proposed m-NAP structure (Figure 2C) is a pentamer of
s-NAP rings. The proposed l-NAP structure (not shown) has mul-
tiple rings with a ratio of one putrescine, one spermidine, and one
spermine along with phosphates ions.
Putrescine is key in initiation of NAP formation in vivo since
its normally low levels would limit the rate of NAP formation.
Also, in initiation of inter-monomer interactions (hydrogen bond-
ing between phosphates) in going from s-NAP to m-NAP, the
putrescine portion of the s-NAP would be important because any
repulsion between the putrescine molecules is neutralized by the
phosphates, whereas spermidine and spermine would still have
internal amines with positive charges that could interfere with
inter-monomer interactions. On the other hand, spermine in the
NAP would be important since it would still have two internal
positive charges available to initiate docking of the NAP to DNA
or RNA (Iacomino et al., 2012). NAPs interacting with DNA, RNA,
or other macro-molecular structures could stabilize autoantigenic
conformations and protect the structures from nucleases and
proteases allowing persistence of the autoantigens.
Nuclear aggregates of polyamines formed in vitro in the pres-
ence of DNA yield quite organized structures wrapped around the
DNA, which could conceivably hamper nuclease digestion in vivo
(Iacomino et al., 2011). However, when NAPs form with chro-
matin in vivo, the resulting complexes would be influenced by the
presence of proteins, the differences in DNA content (AT-rich or
GC-rich) and the presence of supercoiling stress. Polyamines could
self-assemble into NAPs, bind DNA, and stabilize the normally
transient left-hand coiling Z-DNA (Figure 2D) which is a form
of negative supercoiling stress (i.e., unwinding of the right-hand
coiling B-DNA form of the double helix) (Rich and Zhang, 2003).
Particularly effective would be binding of spermine of an s-NAP
in the narrow minor groove of Z-DNA, hydrogen bonding with
the DNA phosphates on either side. Then, as negative supercoiling
stress fluxes through the site and more local flipping to Z-DNA
occurs transiently, the s-NAP will be perfectly aligned to unroll
into the minor groove of the newly formed Z-DNA, stabilizing it
as Z-DNA (D’Agostino et al., 2005). If that s-NAP is part of an
m-NAP, then additional s-NAPs of the m-NAP could also be in
alignment for rapid unfolding (Figure 2D). There could be a fast
moving zipper effect of B-DNA to Z-DNA transition and stabi-
lization by NAPs when there is a large flux of supercoiling stress
released in chromatin. We should note that antibodies targeting
Z-DNA forming sequences are found in systemic lupus erythe-
matosus (SLE) and rheumatoid arthritis (RA) patients and Z-DNA
forming elements are found in SLE sera (Sibley et al., 1984; Van
Helden, 1985; Krishna et al., 1993).
Another form of negative supercoiling stress storage in DNA
is the cruciform. Cruciforms can occur when the DNA double
strands unwind, separate, and intra-strand homologous sequences
hybridize (Figure 3) (Brázda et al., 2011). Alu elements, of which
there are more than 106 in the human genome and which have high
G/C content, have the potential for intra-strand hybridization (as
seen in the Alu domain of the 7SL RNA of the signal recogni-
tion particle) but almost always have a nucleosome positioned in
the Alu DNA element that prevents the cruciform formation. Dis-
placement or disruption of the nucleosome could allow cruciform
formation that could be stabilized by NAPs. The NAPs could also
provide protection from nucleases. We should note that, whereas
Alu elements make up approximately 10% of the human genome,
free DNA in sera of SLE patients is G/C rich and is 55% Alu DNA
(Li and Steinman, 1989; Kreig, 1995).
LIMITING FACTORS: NEGATIVE SUPERCOILING STRESS AND
PUTRESCINE
The stabilization of Z-DNA and cruciforms by polyamines and
NAPs in potentially nuclease resistant autoantigenic forms is lim-
ited by the availability of fluxing negative supercoiling stress and
by the amount of putrescine that can initiate polyamine synthesis
and NAP formation. Most DNA in chromatin is in B-DNA con-
formation, including the DNA in nucleosomes. Also, most DNA
in chromatin is associated with nucleosomes. Z-DNA is less flex-
ible than B-DNA and cannot bend sufficiently to be included in
nucleosomes. In addition, cruciform formation requires strand
unwinding, strand separation, and intra-strand hybridization,
steps that are constrained by nucleosomes. Therefore, due to the
abundance of nucleosomes, Z-DNA and cruciforms occur infre-
quently. Nucleosomes occur every 200 bp on average in humans
with 145 bp wrapped around the histone octamer core and another
approximately 55 bp in the linker DNA between nucleosomes. The
DNA wrapped around the histone core is in B-DNA conformation
but the DNA double strand forms a left-hand supercoil as it wraps
around the histone core (Figure 3). This left-hand supercoil is, in
effect, stored negative supercoiling stress. Each nucleosome con-
tains approximately one negative supercoil. There are 3× 109 bp
in the haploid human genome and, with a nucleosome on aver-
age every 200 bp, there are 30× 106 negative supercoils stored
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FIGURE 2 | Polyamines and NAPs. (A) Components of NAPs. (B)
Small nuclear aggregates of polyamines (s-NAP) proposed by D’Agostino
et al. (2005) consists of phosphate ions with one putrescine, one
spermidine, and two spermines. (C) Medium NAP (m-NAP), as
proposed, consists of pentamers of s-NAPs. (D) Z-DNA stabilization by
spermine versus NAPs. Left: Z-DNA can be co-crystallized with
spermine [based on 2DCG.pdb (Wang et al., 1979) deposited in the
Protein Data Bank, www.rcsb.org (Berman et al., 2000)]. Note how
spermine molecules interact individually with DNA and could be
displaced easily by nucleases. Right: proposed interaction of NAPs with
Z-DNA. An s-NAP could bind in the Z-DNA minor groove, aligning other
polyamines in the NAP to unroll into a growing stretch of Z-DNA.
Polyamines from NAPs would reinforce each other in binding to DNA,
making the DNA less vulnerable to nucleases.
FIGURE 3 | NAPs and chromatin. NAPs bound to chromatin capture negative supercoiling stress released from nucleosomes during NETosis. In this depiction,
NAPs stabilize Z-DNA and cruciforms which are usually transient forms of negative supercoiling. These could become autoantigens when released as part of
NETs.
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in the nuclear chromatin (diploid). Approximately 106 of these
negative supercoils are stored in positioned nucleosomes in Alu
elements suppressing the cruciform formation potential of Alu
elements. Major cellular events that impact chromatin, such as
apoptosis, could rapidly release much of this negative supercoil-
ing stress. As it fluxes through the chromatin, it could flip into
Z-DNA, cruciforms, strand separation, reformation of nucleo-
somes, or be resolved by topoisomerases or protein binding. If
the cellular event involves protein modifications or denaturation
of histones and topoisomerases, then the balance can shift away
from nucleosomes and topoisomerases toward the other forms
of stress storage. Increased polyamines, especially in the form of
NAPs, can help capture this shift in supercoiling stress.
The availability of NAPs depends on an increase in putrescine,
as mentioned previously. Polyamines increase during S phase and
in response to cell stresses, such as oxidative stress (Smirnova et al.,
2012). There would be a temporary increase in putrescine before
it is converted to spermidine and spermine.
Another way in which putrescine levels could become elevated
in a cell is from a viral infection, such as an Epstein–Barr virus
(EBV) infection. EBV is suspected of having a role in autoim-
mune diseases (Toussirot and Roudier, 2008). When EBV becomes
active in a cell, it increases the activity of the c-Myc protein (Bajaj
et al., 2008). The c-Myc protein modulates as much as 15% of
gene expression throughout the genome. Among the genes with
activity enhanced by c-Myc are genes involved in polyamine syn-
thesis: ODC, spermidine synthase (SRM), and spermine synthase
(SMS) (Bello-Fernandez et al., 1993; Nilsson et al., 2005; Hoga-
rty et al., 2008). EBV-induced overexpression of ODC would lead
to an increase in putrescine along with a subsequent decrease in
SAM and cellular methylation since the putrescine would enhance
AMD1 activity. Overall free polyamine availability would also
increase with the enhanced expression of SRM and SMS. Other
viruses may have actions and effects similar to EBV. Bacterial
infections also could increase the available putrescine levels since
bacteria freely produce putrescine without the constraints on ODC
that eukaryotic cells have.
A third way in which putrescine levels could become ele-
vated is increased activity and expression of spermidine/spermine-
N1-acetyltransferase (SAT1), which is involved in recycling of
polyamines. SAT1 is located at Xp22.1 on the X chromosome
and is normally suppressed on the inactive X but expressed from
the active X. SAT1 can undergo super induction (greater than
100-fold increased expression) in the presence of reactive oxy-
gen species (ROS) (Chopra and Wallace, 1998). This can create
an abundance of acetylated polyamines, some of which would be
transported out of the cell or oxidized to the next lower polyamine:
acetylspermine to spermidine or acetylspermidine to putrescine.
In addition, loss of X chromosome inactivation with subsequent
overexpression of SAT1 from both X chromosomes has been pro-
posed as a mechanism in autoimmune diseases (Brooks, 2012).
With age, through many cell cycles and stresses, some of the
X-linked genes can become overexpressed through loss of the
epigenetic control established by X inactivation, which is depen-
dent on methylation. SAT1 overexpression could lead to: excess
putrescine through polyamine recycling; decreased SAM availabil-
ity; and an abundance of acrolein from polyamine degradation.
Acrolein-conjugated proteins are a biomarker in Sjögren’s syn-
drome (SjS) (Higashi et al., 2009). Increased SAT1 and polyamine
recycling have recently been reported in RA (Karouzakis et al.,
2012).
NETosis
Extracellular release of nuclear components appears to have a
role in their development as autoantigens and NETosis provides
such exposure of nuclear components relatively intact compared
to apoptosis or necrosis (Su and Pisetsky, 2009). Therefore, the
recently discovered process of NETosis has drawn significant
interest as potentially being involved in autoimmune diseases
(Brinkmann et al., 2004; Fuchs et al., 2007; Knight and Kaplan,
2012; Darrah and Andrade, 2013). NETosis is a major cellular
event that can bring about the rapid release of the negative super-
coiling stress stored in the nucleus. In NETosis, a neutrophil is
stimulated to modify its chromatin, primarily by citrullination
of histones (Wang et al., 2009). This loosens the nucleosome’s
hold on DNA and thereby releases the stored negative supercoil-
ing allowing unraveling and expansion of the chromatin. Once
the chromatin has been modified, the cell extrudes the chromatin
into the local extracellular environment. In the case of neutrophils,
this modified chromatin is referred to as a “neutrophil extracellu-
lar trap” or NET which binds pathogenic material to make it easier
for macrophages to clear debris at an infection site. This process in
neutrophils is referred to as NETosis but other cells, such as mast
cells, can also undergo the general process referred to as ETosis.
However, NETosis is most intriguing in relation to autoimmune
diseases since neutrophils (a.k.a. granulocytes) are the most abun-
dant of immune cells and are the first to arrive at an infection site
to counter pathogens (Summers et al., 2010). Neutrophils origi-
nate from the bone marrow and can move into most tissues but
they have a very short half-life of only a few hours before they
terminate by apoptosis, necrosis, or other means.
NETosis can be induced in neutrophils by a number of factors
including lipopolysaccharides from pathogens, interleukin-8 (IL-
8), phorbol myristate acetate (PMA), and complement factor C5α
(after priming by interferons I and II) (Wartha et al., 2007). We
should note that EBV induces expression of IL-8 in neutrophils
(McColl et al., 1997). And so an EBV infection, probably with a
heavy viral load in cells, could potentially cause excessive NETo-
sis activity and extracellular release of modified chromatin. Once
NETosis is initiated, cytoplasmic granules merge with the neu-
trophil’s nucleus, releasing enzymes into the nucleus to modify
the chromatin in preparation for extracellular release of the chro-
matin (Parker and Winterbourn, 2013). In addition, generation
of ROS by NADPH oxidase activity adds to the denaturation of
chromatin. The ROS could potentially cause super induction of
SAT1, as mentioned previously.
PEPTIDYL ARGININE DEIMINASES
A key enzyme in the chromatin modification in NETosis is peptidy-
larginine deiminase 4 (PAD4, originally called peptidyl arginine
deiminase V in humans) (Wang et al., 2009; Li et al., 2010). PAD4
localizes to euchromatin in the nucleus whereas other PADs are
cytoplasmic (Nakashima et al., 2002). PAD4 is activated by bind-
ing of calcium ions (Figures 4A,B). Calcium is usually at very low
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FIGURE 4 | Peptidylarginine deiminase 4 (PAD4) and polyamines. (A)
Inactive PAD4 without calcium (top, 1WD8.pdb; Arita et al., 2004) and active
PAD4 (bottom, 1WD9.pdb; Arita et al., 2004) with bound calcium ions (pink
spheres). Note the active site, stabilized helix and loop in active PAD4. (B)
Calcium ions bound in PAD4 primarily by aspartic acid residues. Faint red dash
lines indicate electrostatic interactions. (C) Putrescine superimposed over
calcium ions. (D) Spermidine superimposed over calcium ions. (E) Spermine
superimposed over calcium ions.
levels in the cell (in the range of 100 nM to slightly greater than
1µM) at which PAD4 is inactive whereas extracellular calcium is
in the 1 mM range. In NETosis calcium stored in granules can be
released into the nucleus to activate PAD4.
PAD4 converts the positively charged arginine residues in his-
tones to neutral citrulline residues. This then loosens the hold of
the histones on the DNA in nucleosomes, resulting in expansion
of the modified chromatin due to self-repulsion of the negatively
charged DNA and due to release of DNA supercoiling stress stored
in the nucleosomes. The released stress can flux through the neigh-
boring DNA facilitating unfolding of condensed higher-order
chromatin structures, exposing more histones for modification.
The modified chromatin is then extruded from the cell as a NET
and spreads out to capture pathogens, such as bacteria and fungi
(Wartha and Henriques-Normark, 2008). The neutrophil’s gran-
ules also release anti-microbial peptides into the nucleus, such as
bactericidal permeability increasing (BPI) protein, and enzymes,
such as elastase and myeloperoxidase (Wartha et al., 2007). These
peptides and enzymes including PADs are released with the extra-
cellular NET. The NET/pathogen complexes are then phagocytized
by macrophages and the fragments are scrutinized by the adap-
tive immune system (T cells and B cells). Normally endogenous
DNA and proteins should be tolerated and there should only be
an adaptive immune reaction to exogenous pathogenic material.
The presence of NAPs in the NETs could stabilize and protect
autoantigens from degradation. Enzymes such as the PADs that
are released during NETosis can act on the extracellular proteins
encountered. For example, PADs released during NETosis could
be responsible for the excessive amounts of citrullinated myelin
basic protein seen in multiple sclerosis (MS) or the citrullinated
collagen type II seen in RA.
The initiation of NETosis is believed to depend on an increase
of calcium ions. However, since calcium levels in cells are usu-
ally low (sub µM) and the increase in nuclear levels of calcium
appears to occur only in extraordinary situations, such as NETosis
or apoptosis, it has been suggested that there may be other factors
that can regulate PAD during routine activities, like gene control,
that involves deimination (György et al., 2006). The published
coordinates for PAD4 [1WD9.pdb (Arita et al., 2004) deposited in
the Protein Data Bank, www.rcsb.org; Berman et al., 2000] display
a very interesting possibility (Figure 4B). Five calcium ions bind
PAD4, two near the active site and three toward the center of the
enzyme. The distances approximate the lengths of the polyamines.
It is proposed here that free polyamines could bind PAD4, and per-
haps other PADs, and cause some level of citrullination activity in
spite of low calcium levels (Figures 4C–E).
THE HYPOTHESIS: “NAPs IN NETs”
To summarize the hypothesis, it can be stated as: increased
polyamines can cause potentially detrimental chromatin mod-
ifications and stabilize autoantigens. (1) Hypomethylation of
chromatin can occur due to competition between polyamine
synthesis and cellular methyltransferases for SAM. (2) Inap-
propriate induction of histone citrullination by PAD4, possibly
activated by polyamines, can make neutrophils (and other cell
types) more susceptible to initiation of NETosis (ETosis). (3)
Alternate conformations of nucleic acids, nucleoproteins, and/or
proteins can be stabilized in potentially autoantigenic forms when
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chromatin is disrupted, especially when polyamines and NAPs
increase. When the modified chromatin is released from the cell,
the alterations can persist through macrophage digestion and be
interpreted by the immune system as autoantigens. In addition,
PADs released with the modified chromatin can damage extracel-
lular structures, such as the myelin sheath in MS and connective
tissues in RA.
The possible activation of PADs by polyamines that would make
neutrophils more sensitive to NETotic stimuli or more prone to
initiate NETosis suggests a common mechanism for many of the
autoimmune diseases. The autoantigens and tissue damage that
arise and other disease-specific symptoms would result in part
from the tissue location where the mechanism occurs. For exam-
ple, in MS inflammation isolated behind the blood-brain barrier,
tissue damage by released PADs is the main target whereas in
SLE, a systemic disease with widespread circulation of antibody-
autoantigen complexes, the nuclear autoantigens depositing in the
kidneys and pericardium are usually a greater problem than local-
ized tissue damage at other sites. The involvement of SjS secondary
to SLE, MS, and RA and the fact that acrolein-conjugated pro-
teins are a biomarker in SjS, may be attributable to polyamine
involvement in these diseases.
The “NAPs in NETs” hypothesis suggests some interesting pos-
sibilities. For example, the female:male ratio of SLE patients is
approximately 9:1 suggesting possible influence of the X chro-
mosome and/or the X inactivation process. Alu elements have an
important role in SLE according to the hypothesis. Whereas Alu
elements account for approximately 10% of the human genome,
they comprise only 8% of the X chromosome (Ross et al., 2005).
However, the Alu composition jumps to ∼29% in the pseudo-
autosomal region 1 (PAR1) of the X short arm and is ∼19%
in the adjacent S5 region. Most Alu elements are silenced by a
positioned nucleosome over the RNA polymerase III intragenic
promoter boxes. These positioned nucleosomes would also sup-
press cruciform formation within the Alu DNA. This Alu DNA
could form cruciforms when the nucleosomes are displaced during
NETosis. With the extensive packaging in the inactive X chromo-
some which keeps greater than 75% of its genes silenced, there
would be more stored supercoiling stress that could be rapidly
released and stabilized in cruciforms or Z-DNA during NETosis,
particularly in the PAR1 and S5 regions of the inactive X. The
inactive X chromosome in females and Klinefelter’s males (XXY),
but not in other males, could contribute to the female:male ratio
in SLE.
FUTURE PERSPECTIVES
This “NAPs in NETs” hypothesis is compatible with several
other hypotheses of autoimmune diseases. Proponents of those
hypotheses may wish to consider the synergies. For example,
the “hygiene hypothesis” attributes a protective role to helminth
worms. The helminths take up polyamines and appear depen-
dent on their host for polyamine synthesis (Sharma et al., 1991).
This suggests helminths help modulate overall polyamine levels
in the host. The “leaky gut” hypothesis fits well since bacteria
in the intestines are a source of polyamines. A leaky gut could
allow excessive amounts of polyamines to enter the circulation.
The “molecular mimicry” hypothesis also fits since, for exam-
ple, molecules mimicking IL-8 or PMA could trigger NETosis in
neutrophils, especially if they have been potentiated by polyamine-
activated PADs.“NAPs in NETs”also supports the“common cause”
hypothesis of autoimmune diseases. Although “NAPs in NETs”
places more emphasis on epigenetics, genetics-based hypotheses
can align with “NAPs in NETs.” For example, some HLA types
may be more permissive to EBV entry into cells, thereby creat-
ing lymphocytes with a heavier viral load and increase in viral
induced polyamine synthesis (Li et al., 1997). One could envi-
sion EBV-infected cells at an infection site inducing IL-8 mediated
polyamine-potentiated NETosis that releases more EBV, which
infects more cells. A critical mass builds up to a persistent inflam-
mation, the whole time PADs and autoantigens are being released
extending the damage and response.
Although the“NAPs in NETs”hypothesis is complicated, it does
suggest some obvious experiments. PAD activity could be ana-
lyzed in a range of concentrations of calcium and of polyamines.
Polyamines alone may not activate PADs but they may greatly
lower the threshold such that much lower concentrations of cal-
cium can activate PADs. Another set of experiments could test
the nuclease sensitivity of negatively supercoiled plasmid DNA
with potential Z-DNA forming sequences (e.g., alternating purine-
pyrimidine) in the presence/absence of NAPs. NAPs are interest-
ing new phenomena to explore but increases in the individual
polyamines also need further exploration. For example, immu-
nization of rabbits with spermine alone induces autoantibodies
targeting, DNA, and histones (Atanassov et al., 1993). Certainly
drug discovery efforts to find new therapeutics to treat autoim-
mune diseases should intensify to target the PADs and enzymes
involved in polyamine synthesis and recycling. The potential has
been demonstrated by use of difluoromethylornithine (DFMO),
an inhibitor of ODC, to suppress lupus-like symptoms in mouse
models of lupus (Thomas and Messner, 1991).
CONCLUSION
The “NAPs in NETs” hypothesis suggests that epigenetics and the
innate immune response have significant roles in autoimmune
diseases. This is quite different from the emphasis on genetics
and possible abnormalities in the adaptive immune response that
have been the focus of most autoimmune disease research over the
past decades. Epigenetics and autoimmunity as a topic is receiving
more attention recently as we try to understand the relation-
ship between genetics and environmental factors in autoimmune
diseases (Brooks et al., 2010).
What has been presented here as the “NAPs in NETs” hypothe-
sis is actually a collection of hypotheses, each of which has its own
merits, possible shortcomings, and open questions. Polyamine
activation of PADs can be considered as one hypothesis. NAP
stabilization of Z-DNA and/or cruciforms into autoantigens is
another hypothesis. The importance of Alu elements, especially in
PAR1 and S5 of the X chromosome, is yet another hypothesis. The
discussion has focused mainly on neutrophils and NETosis but
other cell types could be involved with similar problems from
excess polyamines, loss of dosage compensation, inappropriate
PAD activity, and/or ETosis (Goldman and Medina, 2013).
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